BioSpace News Archive

A new study suggests opioid use can be minimized for patients during the surgical recovery period with the infusion of a local anesthetic through a nerve catheter delivered via intermittent boluses and over a longer duration of time. Patients in the study were connected to a Nimbus II PainPRO, a non-narcotic ambulatory infusion pump distributed by InfuTronix Solutions.

Guardant Health, Inc., announced that Palmetto GBA, a Medicare Administrative Contractor for the Molecular Diagnostics program, has expanded local coverage determination of the Guardant360® assay, making it the first and only liquid biopsy to be broadly covered for use across the vast majority of advanced solid tumors.

The Government of Canada is concerned by the rapid rise in youth vaping, and is taking action to address it.

Adamis Pharmaceuticals Corporation provided an update on the ZIMHI™ New Drug Application resubmission process.

The AOAC’s Performance TestedSM Method Certification provides independent validation of the ability of the Soleris for EBAC test to accurately detect EBAC in a wide variety of sample types.

Walnut Creek Surgeon Joins AAOS Board of Councilors for a 3-Year Term

MDA is focused on driving innovations in research and care for people living with neuromuscular diseases.

The offering is expected to close on or about December 23, 2019 subject to customary closing conditions.

Nitric oxide release technology will have broad applications for unmet needs in diabetic health management

Six physician-scientists from the U.S. and Canada selected for drug development grant